CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 21 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00283-07v1
15/2/215    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varshney, A. K.
Right arrow Articles by Malhotra, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varshney, A. K.
Right arrow Articles by Malhotra, P.
Clin. Vaccine Immunol. doi:10.1128/CVI.00283-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Cloning, Expression and Immunological Characterization of P30 protein of Mycoplasma pneumoniae

Avanish Kumar Varshney, Rama Chaudhry*, Sushil Kumar Kabra, and Pawan Malhotra*

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India; Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India; International Center for Genetic Engineering and Biotechnology, New Delhi, India

* To whom correspondence should be addressed. Email: ramach{at}aiims.ac.in. pawanm{at}icgeb.res.in.


   Abstract

Mycoplasma pneumoniae, a self-replicating cell wall deficient prokaryote has a differentiated terminal organelle that is essential for cytadherence and gliding motility. P30, an important protein associated with the terminal organelle is required for cytadherence and virulence of M. pneumoniae. P30 is a transmembrane protein with an intracytoplasmic N-terminal and exposed C- terminal. In the present study, we amplified and sequenced the full length p30 gene of Mycoplasma pneumoniae directly from eighteen Indian asthmatic patients. Sequence diversity was observed in p30 gene from sixteen clinical samples when compared with M-129 strain. We also successfully expressed a fragment of p30 gene (P30-B) that includes the complete C-terminal proline-rich amino acid sequences in different E. coli expression system. The MBP-P30B fusion protein was recognized by M. pneumoniae infected patient sera in immunoblot and the protein was immunogenic in mice. We further analyzed the reactivity of MBP-P30B fusion protein with patient sera in an ELISA and compared it with the commercial kit (Serion ELISA Classic kit). The sensitivity and specificity of in-house ELISA was 78.57% and 89.47% respectively. This study suggests that P30 protein can be used as an antigen for immunodiagnosis for M. pneumoniae infection along with other adhesin proteins.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.